PDX samples with genetic profiles that include driver mutations are highly significant for developing therapeutic drugs against diseases ( Sun et al., 2021 ).
← all excerpts
Therapeutic target biomarkers of patient-derived xenograft models of gastric-type cervical adenocarcinoma.
1
—
—